Trial · NCT02371759
Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2
NCT02371759, Phase 3, Completed, University of Belgrade; results first posted 2017-05-03
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2. Trials, record NCT02371759. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02371759
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2
- NCT number
- NCT02371759
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 256 participants, actual
- Lead sponsor
- University of Belgrade
- Conditions
- Diabetes Mellitus, Local Anesthesia
- Interventions
- L+C maxillary anesthesia, L+C mandibular anesthesia, L+E maxillary anesthesia, L+E mandibular anesthesia
- First posted
- 2015-02-26
- Last updated
- 2017-05-03
- Results first posted
- 2017-05-03
Source ClinicalTrials.gov
Registered outcomes25
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Duration of Intraoral Local Anesthesia | Up to 6 hours after local anesthesia injection | Time until cessation in soft tissue numbness |
| Primary | Intensity of Intraoral Local Anesthesia | Up to 10 minutes after local anesthesia injection | Number of participants who reported values \> 0 after pin-prick testing, using Visual Analogue Scale (VAS) and Numerical Rating Scale (NRS). VAS is represented by line 100 mm long, with one end marked with 0 and words "no pain" , while the other end is marked with 100 and words "the worst pain imanginable". VRS scale is represented by line 100 mm long, marked with numbers from 0 to 10, where 0 corresponds to "no pain", and 10 corresponds to "the worst pain imaginable". For both scales, higher scores represent worse outcomes. |
| Primary | Baseline Systolic Blood Pressure | Baseline, 0 minutes | |
| Primary | Systolic Blood Pressure at 10 Minutes | 10th minute | Systolic blood pressure values 5 minutes after local anesthesia injection |
| Primary | Systolic Blood Pressure at 15 Minutes | 15th minute | Systolic blood pressure values 10 minutes after local anesthesia injection |
| Primary | Systolic Blood Pressure at 20 Minutes | 20th minute | Systolic blood pressure values 15 minutes after local anesthesia injection |
| Primary | Systolic Blood Pressure at 35 Minutes | 35th minute | Systolic blood pressure values 30 minutes after local anesthesia injection |
| Primary | Baseline Diastolic Blood Pressure | baseline, 0 minutes | |
| Primary | Diastolic Blood Pressure at 10 Minutes | 10th minute | Diastolic blood pressure values 5 minutes after local anesthesia injection |
| Primary | Diastolic Blood Pressure at 15 Minutes | 15th minute | Diastolic blood pressure values 10 minutes after local anesthesia injection |
1 to 10 of 25Source ClinicalTrials.gov
See all 25 registered outcomesOutcomes25
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Duration of Intraoral Local Anesthesia | Up to 6 hours after local anesthesia injection | minutes | MEAN | |
| PRIMARY | Intensity of Intraoral Local Anesthesia | Up to 10 minutes after local anesthesia injection | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Baseline Systolic Blood Pressure | Baseline, 0 minutes | milimeters of Hg | MEAN | |
| PRIMARY | Systolic Blood Pressure at 10 Minutes | 10th minute | milimeters of Hg | MEAN | |
| PRIMARY | Systolic Blood Pressure at 15 Minutes | 15th minute | milimeters of Hg | MEAN | |
| PRIMARY | Systolic Blood Pressure at 20 Minutes | 20th minute | milimeters of Hg | MEAN | |
| PRIMARY | Systolic Blood Pressure at 35 Minutes | 35th minute | milimeters of Hg | MEAN | |
| PRIMARY | Baseline Diastolic Blood Pressure | baseline, 0 minutes | milimeters of Hg | MEAN | |
| PRIMARY | Diastolic Blood Pressure at 10 Minutes | 10th minute | milimeters of Hg | MEAN | |
| PRIMARY | Diastolic Blood Pressure at 15 Minutes | 15th minute | milimeters of Hg | MEAN |
1 to 10 of 25Source ClinicalTrials.gov
See all 25 outcomesResults by group200
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Duration of Intraoral Local Anesthesia | Diabetics: L+C Maxillary Anesthesia | 132.48 | Standard Deviation 91.86 | minutes | |
| Duration of Intraoral Local Anesthesia | Diabetics: L+C Mandibular Anesthesia | 173.27 | Standard Deviation 70.44 | minutes | |
| Duration of Intraoral Local Anesthesia | Diabetics: L+E Maxillary Anesthesia | 182.09 | Standard Deviation 57.86 | minutes | |
| Duration of Intraoral Local Anesthesia | Diabetics: L+E Mandibular Anesthesia | 195.35 | Standard Deviation 68.99 | minutes | |
| Duration of Intraoral Local Anesthesia | Healthy: L+C Maxillary Anesthesia | 108.82 | Standard Deviation 27.76 | minutes | |
| Duration of Intraoral Local Anesthesia | Healthy: L+C Mandibular Anesthesia | 155.59 | Standard Deviation 60.75 | minutes | |
| Duration of Intraoral Local Anesthesia | Healthy: L+E Maxillary Anesthesia | 114.74 | Standard Deviation 39.72 | minutes | |
| Duration of Intraoral Local Anesthesia | Healthy: L+E Mandibular Anesthesia | 172.91 | Standard Deviation 68.93 | minutes | |
| Intensity of Intraoral Local Anesthesia | Diabetics: L+C Maxillary Anesthesia | 2 | Participants | ||
| Intensity of Intraoral Local Anesthesia | Diabetics: L+C Mandibular Anesthesia | 2 | Participants |
1 to 10 of 200Source ClinicalTrials.gov
See all 200 results by groupParticipant flow24
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Diabetics: L+C Maxillary Anesthesia | 32 | |
| Overall Study | STARTED | Diabetics: L+C Mandibular Anesthesia | 31 | |
| Overall Study | STARTED | Diabetics: L+E Maxillary Anesthesia | 33 | |
| Overall Study | STARTED | Diabetics: L+E Mandibular Anesthesia | 31 | |
| Overall Study | STARTED | Healthy: L+C Maxillary Anesthesia | 27 | |
| Overall Study | STARTED | Healthy: L+C Mandibular Anesthesia | 26 | |
| Overall Study | STARTED | Healthy: L+E Maxillary Anesthesia | 25 | |
| Overall Study | STARTED | Healthy: L+E Mandibular Anesthesia | 28 | |
| Overall Study | COMPLETED | Diabetics: L+C Maxillary Anesthesia | 29 | |
| Overall Study | COMPLETED | Diabetics: L+C Mandibular Anesthesia | 30 |
1 to 10 of 24Source ClinicalTrials.gov
See all 24 participant flowAdverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals24
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Diabetics: L+C Maxillary Anesthesia | ||
| Total, all-cause mortality | Diabetics: L+C Mandibular Anesthesia | ||
| Total, all-cause mortality | Diabetics: L+E Maxillary Anesthesia | ||
| Total, all-cause mortality | Diabetics: L+E Mandibular Anesthesia | ||
| Total, all-cause mortality | Healthy: L+C Maxillary Anesthesia | ||
| Total, all-cause mortality | Healthy: L+C Mandibular Anesthesia | ||
| Total, all-cause mortality | Healthy: L+E Maxillary Anesthesia | ||
| Total, all-cause mortality | Healthy: L+E Mandibular Anesthesia | ||
| Total, other adverse events | Diabetics: L+C Maxillary Anesthesia | 0 | 29 |
| Total, other adverse events | Diabetics: L+C Mandibular Anesthesia | 0 | 30 |
1 to 10 of 24Source ClinicalTrials.gov
See all 24 adverse event totalsPapers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02371759
GET https://conductscience.org/api/trials/v1/NCT02371759/registered?page=2